Potential response to curcumin in infantile hemangioendothelioma of the liver

Pediatric Blood and Cancer

Volumn 55, Issue 2, 2010, Pages 377-379

  Hassell, Lewis A ^a   Roanh, Le Dinh ^b  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b Center for Research and Early Detection of Cancer   (Viet Nam)

Author keywords

Angiogenesis factors; Curcumin; Infantile hemangioendothelioma of liver

Indexed keywords

CURCUMIN;

ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HEMANGIOENDOTHELIOMA; HEPATOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; INFANTILE HEMANGIOENDOTHELIOMA; LIVER BIOPSY; LIVER TUMOR; MALE; PRIORITY JOURNAL; TREATMENT RESPONSE; ULTRASOUND;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; CURCUMIN; DIAGNOSTIC IMAGING; DIETARY SUPPLEMENTS; HEMANGIOENDOTHELIOMA; HUMANS; INFANT; LIVER NEOPLASMS; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 77955121654     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22538     Document Type: Article

References (20)

1. 1pi.oregonstate.edu/infocenter/phytochemicals/curcumin [accessed November 30, 2009].
2. Arbiser JL, Klauber N, Rohan R, et al. Curcumin is an in vivo inhibitor of angiogenesis. Mol Med 1998;4:376-383.
3. National Institutes of Health. Use of curcumin for treatment of intestinal adenomas in familial adenomatous polyposis (FAP). clinicaltrials.gov/ct2/show/NCT00927485?intr=%22Curcumin%22& rank=2 [accessed November 30, 2009].
4. National Institutes of Health. Curcumin with pre-operative capecitabine and radiation therapy followed by surgery for rectal cancer. clinicaltrials.gov/ct2/show?intr=%22Curcumin%22&rank=7 [accessed November 30, 2009].
5. National Institutes of Health. Trial of curcumin in cutaneous t-cell lymphoma patients. clinicaltrials.gov/ct2/show?intr=%22Curcumin%22& rank=10 [accessed November 30, 2009].
6. National Institutes of Health. Trial of curcumin in advanced pancreatic cancer. clinicaltrials.gov/ct2/show/NCT00094445 [accessed November 30, 2009].
7. Sharma RA, Euden SA, Platton SL, et al. Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance. Clin Cancer Res 2004;10:6847.
8. Chen CC, Kong MS, Yang CP, et al. Hepatic hemangioendothelioma in children: Analysis of thirteen cases. Acta Paediatr Taiwan 2003;44:8-13. (Pubitemid 36538177)
9. Presedo A, Martínez-Ibáñez V, Castellote A, et al. Infantile hepatic hemangioendothelioma of the liver: Report of 11 cases. Cir Pediatr 1996;9:51-54 [article in Spanish].
10. Daller JA, Bueno J, Gutierrez J, et al. Hepatic hemangioendothelioma: Clinical experience and management strategy. J Pediatr Surg 1999;34:98-105, discussion 105-106.
11. Buckmiller LM. Propranolol treatment for infantile hemangiomas. Curr Opin Otolaryngol Head Neck Surg 2009;17:458-459.
12. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649-2651.
13. Christison-Lagay ER, Burrows PE, Alomari A, et al. Hepatic hemangiomas: Subtype classification and development of a clinical practice algorithm and registry. J Ped Surg 2007;42:62-68.
14. Kassarjian A, Zurakowski D, Dubois J, et al. Infantile hepatic hemangiomas: Clinical and imaging findings and their correlation with therapy. AJR Am J Roentgenol 2004;182:785-795.
15. Mo JQ, Dimashkieh HH, Bove KE. GLUT1 endothelial reactivity distinguishes hepatic infantile hemangioma from congenital hepatic vascular malformation with associated capillary proliferation. Hum Pathol 2004;35:200-209.
16. Hernandez F, Navarro M, Encinas JL, et al. The role of GLUT1 immunostaining in the diagnosis and classification of liver vascular tumors in children. J Pediatr Surg 2005;40:801-804.
17. Singh S, Aggarwal BB. Activation of transcription factor NF-κB is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem 1995;270:24995-25000.
18. Aggarwal S, Ichikawa H, Takada Y, et al. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IκBα kinase and Akt activation. Mol Pharmacol 2006;69:195-206.
19. "Curcumin and Turmeric," Advanced Health Life Extension, Clear Springs Press. www.advance-health.com/curcumin.html.
20. Moos PJ, Edes K, Mullally JE, et al. Curcumin impairs tumor suppressor p53 function in colon cancer cells. Carcinogenesis 2004;25:1611-1617.